{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:09:55Z","timestamp":1794755395980,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:00:00Z","timestamp":1557273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The respiratory syncytial virus (RSV) F glycoprotein is a class I fusion protein that mediates viral entry and is a major target of neutralizing antibodies. Structures of prefusion forms of RSV F, as well as other class I fusion proteins, have revealed compact trimeric arrangements, yet whether these trimeric forms can transiently open remains unknown. Here, we perform structural and biochemical studies on a recently isolated antibody, CR9501, and demonstrate that it enhances the opening of prefusion-stabilized RSV F trimers. The 3.3\u2009\u00c5 crystal structure of monomeric RSV F bound to CR9501, combined with analysis of over 25 previously determined RSV F structures, reveals a breathing motion of the prefusion conformation. We also demonstrate that full-length RSV F trimers transiently open and dissociate on the cell surface. Collectively, these findings have implications for the function of class I fusion proteins, as well as antibody prophylaxis and vaccine development for RSV.<\/jats:p>","DOI":"10.1038\/s41467-019-09807-5","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T15:35:48Z","timestamp":1557416148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Transient opening of trimeric prefusion RSV F proteins"],"prefix":"10.1038","volume":"10","author":[{"given":"Morgan S. A.","family":"Gilman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Furmanova-Hollenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3705-2392","authenticated-orcid":false,"given":"Ang\u00e9lique","family":"B. van \u2018t Wout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes P. M.","family":"Langedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-542X","authenticated-orcid":false,"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,8]]},"reference":[{"key":"9807_CR1","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00705-016-2880-1","volume":"161","author":"CL Afonso","year":"2016","unstructured":"Afonso, C. L. et al. Taxonomy of the order Mononegavirales: update 2016. Arch. Virol. 161, 2351\u20132360 (2016).","journal-title":"Arch. Virol."},{"key":"9807_CR2","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi, T. et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 390, 946\u2013958 (2017).","journal-title":"Lancet"},{"key":"9807_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2165\/00019053-200422050-00001","volume":"22","author":"LC Paramore","year":"2004","unstructured":"Paramore, L. C., Ciuryla, V., Ciesla, G. & Liu, L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 22, 275\u2013284 (2004).","journal-title":"Pharmacoeconomics"},{"key":"9807_CR4","first-page":"53","volume":"2","author":"A Shahabi","year":"2018","unstructured":"Shahabi, A., Peneva, D., Incerti, D., McLaurin, K. & Stevens, W. Assessing variation in the cost of palivizumab for respiratory syncytial virus prevention in preterm infants. Pharm. Open 2, 53\u201361 (2018).","journal-title":"Pharm. Open"},{"key":"9807_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1542\/peds.102.3.531","volume":"102","author":"The IMpact-RSV Study Group.","year":"1998","unstructured":"The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531\u2013537 (1998).","journal-title":"Pediatrics"},{"key":"9807_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1006\/viro.2001.1138","volume":"289","author":"MN Teng","year":"2001","unstructured":"Teng, M. N., Whitehead, S. S. & Collins, P. L. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 289, 283\u2013296 (2001).","journal-title":"Virology"},{"key":"9807_CR7","doi-asserted-by":"publisher","first-page":"13961","DOI":"10.1073\/pnas.94.25.13961","volume":"94","author":"RA Karron","year":"1997","unstructured":"Karron, R. A. et al. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA 94, 13961\u201313966 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9807_CR8","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1128\/JVI.75.15.6825-6834.2001","volume":"75","author":"S Techaarpornkul","year":"2001","unstructured":"Techaarpornkul, S., Barretto, N. & Peeples, M. E. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and\/or attachment glycoprotein gene. J. Virol. 75, 6825\u20136834 (2001).","journal-title":"J. Virol."},{"key":"9807_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1126\/science.1234914","volume":"340","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340, 1113\u20131117 (2013).","journal-title":"Science"},{"key":"9807_CR10","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1128\/JVI.00555-11","volume":"85","author":"JS McLellan","year":"2011","unstructured":"McLellan, J. S., Yang, Y., Graham, B. S. & Kwong, P. D. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J. Virol. 85, 7788\u20137796 (2011).","journal-title":"J. Virol."},{"key":"9807_CR11","doi-asserted-by":"publisher","first-page":"9619","DOI":"10.1073\/pnas.1106536108","volume":"108","author":"KA Swanson","year":"2011","unstructured":"Swanson, K. A. et al. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc. Natl. Acad. Sci. USA 108, 9619\u20139624 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9807_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archpedi.1977.02120150027004","volume":"131","author":"FW Bruhn","year":"1977","unstructured":"Bruhn, F. W. & Yeager, A. S. Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection. Am. J. Dis. Child 131, 145\u2013148 (1977).","journal-title":"Am. J. Dis. Child"},{"key":"9807_CR13","first-page":"463","volume":"95","author":"JR Groothuis","year":"1995","unstructured":"Groothuis, J. R., Simoes, E. A. & Hemming, V. G. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics 95, 463\u2013467 (1995).","journal-title":"Pediatrics"},{"issue":"Pt 12","key":"9807_CR14","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1099\/0022-1317-68-12-3125","volume":"68","author":"C Orvell","year":"1987","unstructured":"Orvell, C., Norrby, E. & Mufson, M. A. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J. Gen. Virol. 68(Pt 12), 3125\u20133135 (1987).","journal-title":"J. Gen. Virol."},{"key":"9807_CR15","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1128\/JVI.72.8.6922-6928.1998","volume":"72","author":"JA Lopez","year":"1998","unstructured":"Lopez, J. A. et al. Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J. Virol. 72, 6922\u20136928 (1998).","journal-title":"J. Virol."},{"key":"9807_CR16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/jvi.63.2.925-932.1989","volume":"63","author":"B Garcia-Barreno","year":"1989","unstructured":"Garcia-Barreno, B. et al. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J. Virol. 63, 925\u2013932 (1989).","journal-title":"J. Virol."},{"issue":"Pt 9","key":"9807_CR17","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1099\/0022-1317-73-9-2225","volume":"73","author":"J Arbiza","year":"1992","unstructured":"Arbiza, J. et al. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J. Gen. Virol. 73(Pt 9), 2225\u20132234 (1992).","journal-title":"J. Gen. Virol."},{"key":"9807_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.coviro.2015.03.002","volume":"11","author":"JS McLellan","year":"2015","unstructured":"McLellan, J. S. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. Curr. Opin. Virol. 11, 70\u201375 (2015).","journal-title":"Curr. Opin. Virol."},{"key":"9807_CR19","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/jvi.63.7.2941-2950.1989","volume":"63","author":"JA Beeler","year":"1989","unstructured":"Beeler, J. A. & van Wyke Coelingh, K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J. Virol. 63, 2941\u20132950 (1989).","journal-title":"J. Virol."},{"key":"9807_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1086\/514115","volume":"176","author":"S Johnson","year":"1997","unstructured":"Johnson, S. et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J. Infect. Dis. 176, 1215\u20131224 (1997).","journal-title":"J. Infect. Dis."},{"issue":"Pt 12","key":"9807_CR21","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1099\/0022-1317-74-12-2567","volume":"74","author":"JA Lopez","year":"1993","unstructured":"Lopez, J. A. et al. Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein. J. Gen. Virol. 74(Pt 12), 2567\u20132577 (1993).","journal-title":"J. Gen. Virol."},{"key":"9807_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nsmb.1723","volume":"17","author":"JS McLellan","year":"2010","unstructured":"McLellan, J. S. et al. Structural basis of respiratory syncytial virus neutralization by motavizumab. Nat. Struct. Mol. Biol. 17, 248\u2013250 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"9807_CR23","doi-asserted-by":"publisher","first-page":"aaj1879","DOI":"10.1126\/sciimmunol.aaj1879","volume":"1","author":"MS Gilman","year":"2016","unstructured":"Gilman, M. S. et al. Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Sci. Immunol. 1, aaj1879 (2016).","journal-title":"Sci. Immunol."},{"key":"9807_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nm.2071","volume":"16","author":"MJ Kwakkenbos","year":"2010","unstructured":"Kwakkenbos, M. J. et al. Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat. Med 16, 123\u2013128 (2010).","journal-title":"Nat. Med"},{"key":"9807_CR25","doi-asserted-by":"publisher","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","volume":"7","author":"JO Ngwuta","year":"2015","unstructured":"Ngwuta, J. O. et al. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci. Transl. Med. 7, 309ra162 (2015).","journal-title":"Sci. Transl. Med."},{"key":"9807_CR26","doi-asserted-by":"publisher","first-page":"16271","DOI":"10.1038\/nmicrobiol.2016.271","volume":"2","author":"JJ Mousa","year":"2017","unstructured":"Mousa, J. J., Kose, N., Matta, P., Gilchuk, P. & Crowe, J. E. Jr. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Nat. Microbiol. 2, 16271 (2017).","journal-title":"Nat. Microbiol."},{"key":"9807_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/viro.2002.1497","volume":"298","author":"M Begona Ruiz-Arguello","year":"2002","unstructured":"Begona Ruiz-Arguello, M. et al. Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment. Virology 298, 317\u2013326 (2002).","journal-title":"Virology"},{"key":"9807_CR28","doi-asserted-by":"publisher","first-page":"9859","DOI":"10.1073\/pnas.151098198","volume":"98","author":"L Gonzalez-Reyes","year":"2001","unstructured":"Gonzalez-Reyes, L. et al. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc. Natl. Acad. Sci. USA 98, 9859\u20139864 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9807_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0168-1702(00)00149-0","volume":"68","author":"G Bolt","year":"2000","unstructured":"Bolt, G., Pedersen, L. O. & Birkeslund, H. H. Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin. Virus Res. 68, 25\u201333 (2000).","journal-title":"Virus Res."},{"key":"9807_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0042-6822(77)90380-4","volume":"80","author":"A Scheid","year":"1977","unstructured":"Scheid, A. & Choppin, P. W. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology 80, 54\u201366 (1977).","journal-title":"Virology"},{"key":"9807_CR31","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1128\/JVI.77.8.4609-4616.2003","volume":"77","author":"J Schlender","year":"2003","unstructured":"Schlender, J., Zimmer, G., Herrler, G. & Conzelmann, K. K. Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection. J. Virol. 77, 4609\u20134616 (2003).","journal-title":"J. Virol."},{"key":"9807_CR32","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1099\/vir.0.055368-0","volume":"94","author":"HA Lawlor","year":"2013","unstructured":"Lawlor, H. A., Schickli, J. H. & Tang, R. S. A single amino acid in the F2 subunit of respiratory syncytial virus fusion protein alters growth and fusogenicity. J. Gen. Virol. 94, 2627\u20132635 (2013).","journal-title":"J. Gen. Virol."},{"key":"9807_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9143","volume":"6","author":"A Krarup","year":"2015","unstructured":"Krarup, A. et al. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat. Commun. 6, 8143 (2015).","journal-title":"Nat. Commun."},{"key":"9807_CR34","doi-asserted-by":"crossref","first-page":"JVI.01323","DOI":"10.1128\/JVI.01323-17","volume":"92","author":"IM Bermingham","year":"2018","unstructured":"Bermingham, I. M., Chappell, K. J., Watterson, D. & Young, P. R. The Heptad Repeat C domain of the respiratory syncytial virus fusion protein plays a key role in membrane fusion. J. Virol. 92, JVI.01323\u201317 (2018).","journal-title":"J. Virol."},{"key":"9807_CR35","doi-asserted-by":"publisher","first-page":"JVI.00621","DOI":"10.1128\/JVI.00621-18","volume":"92","author":"SN Hicks","year":"2018","unstructured":"Hicks, S. N. et al. Five residues in the apical loop of the respiratory syncytial virus fusion protein F2 subunit are critical for its fusion activity. J. Virol. 92, JVI.00621\u201318 (2018).","journal-title":"J. Virol."},{"key":"9807_CR36","doi-asserted-by":"publisher","first-page":"e0128779","DOI":"10.1371\/journal.pone.0128779","volume":"10","author":"GB Stewart-Jones","year":"2015","unstructured":"Stewart-Jones, G. B. et al. A cysteine zipper stabilizes a pre-fusion F glycoprotein vaccine for respiratory syncytial virus. PLoS ONE 10, e0128779 (2015).","journal-title":"PLoS ONE"},{"key":"9807_CR37","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1073\/pnas.1523303113","volume":"113","author":"JJ Wong","year":"2016","unstructured":"Wong, J. J., Paterson, R. G., Lamb, R. A. & Jardetzky, T. S. Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form. Proc. Natl. Acad. Sci. USA 113, 1056\u20131061 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9807_CR38","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nature04322","volume":"439","author":"HS Yin","year":"2006","unstructured":"Yin, H. S., Wen, X., Paterson, R. G., Lamb, R. A. & Jardetzky, T. S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439, 38\u201344 (2006).","journal-title":"Nature"},{"key":"9807_CR39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","volume":"342","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592\u2013598 (2013).","journal-title":"Science"},{"key":"9807_CR40","doi-asserted-by":"publisher","first-page":"e1005035","DOI":"10.1371\/journal.ppat.1005035","volume":"11","author":"MS Gilman","year":"2015","unstructured":"Gilman, M. S. et al. Characterization of a prefusion-specific antibody that recognizes a quaternary, cleavage-dependent epitope on the RSV fusion glycoprotein. PLoS Pathog. 11, e1005035 (2015).","journal-title":"PLoS Pathog."},{"key":"9807_CR41","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.jmb.2018.04.015","volume":"430","author":"A Abou-Hamdan","year":"2018","unstructured":"Abou-Hamdan, A., Belot, L., Albertini, A. & Gaudin, Y. Monomeric intermediates formed by vesiculovirus glycoprotein during its low-pH-induced structural transition. J. Mol. Biol. 430, 1685\u20131695 (2018).","journal-title":"J. Mol. Biol."},{"key":"9807_CR42","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1099\/vir.0.051136-0","volume":"94","author":"KJ Cho","year":"2013","unstructured":"Cho, K. J. et al. Insight into structural diversity of influenza virus haemagglutinin. J. Gen. Virol. 94, 1712\u20131722 (2013).","journal-title":"J. Gen. Virol."},{"key":"9807_CR43","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/nm.4223","volume":"22","author":"DD Raymond","year":"2016","unstructured":"Raymond, D. D. et al. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain. Nat. Med. 22, 1465\u20131469 (2016).","journal-title":"Nat. Med"},{"key":"9807_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.coviro.2013.03.006","volume":"3","author":"E Baquero","year":"2013","unstructured":"Baquero, E. et al. Intermediate conformations during viral fusion glycoprotein structural transition. Curr. Opin. Virol. 3, 143\u2013150 (2013).","journal-title":"Curr. Opin. Virol."},{"key":"9807_CR45","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1126\/science.1254426","volume":"346","author":"JB Munro","year":"2014","unstructured":"Munro, J. B. et al. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science 346, 759\u2013763 (2014).","journal-title":"Science"},{"key":"9807_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature07159","volume":"455","author":"J Liu","year":"2008","unstructured":"Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G. & Subramaniam, S. Molecular architecture of native HIV-1 gp120 trimers. Nature 455, 109\u2013113 (2008).","journal-title":"Nature"},{"key":"9807_CR47","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.str.2014.05.001","volume":"22","author":"M Guttman","year":"2014","unstructured":"Guttman, M. et al. CD4-induced activation in a soluble HIV-1 Env trimer. Structure 22, 974\u2013984 (2014).","journal-title":"Structure"},{"key":"9807_CR48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.celrep.2018.03.061","volume":"23","author":"L Rutten","year":"2018","unstructured":"Rutten, L. et al. A universal approach to optimize the folding and stability of prefusion-closed HIV-1 envelope trimers. Cell Rep. 23, 584\u2013595 (2018).","journal-title":"Cell Rep."},{"key":"9807_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9167","volume":"6","author":"JH Lee","year":"2015","unstructured":"Lee, J. H. et al. Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike. Nat. Commun. 6, 8167 (2015).","journal-title":"Nat. Commun."},{"key":"9807_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/v10080446","volume":"10","author":"Z Ke","year":"2018","unstructured":"Ke, Z. et al. The morphology and assembly of respiratory syncytial virus revealed by cryo-electron tomography. Viruses 10, 446 (2018).","journal-title":"Viruses"},{"key":"9807_CR51","doi-asserted-by":"publisher","first-page":"11133","DOI":"10.1073\/pnas.1309070110","volume":"110","author":"L Liljeroos","year":"2013","unstructured":"Liljeroos, L., Krzyzaniak, M. A., Helenius, A. & Butcher, S. J. Architecture of respiratory syncytial virus revealed by electron cryotomography. Proc. Natl. Acad. Sci. USA 110, 11133\u201311138 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9807_CR52","doi-asserted-by":"publisher","first-page":"e00270-11","DOI":"10.1128\/mBio.00270-11","volume":"3","author":"FY Shaikh","year":"2012","unstructured":"Shaikh, F. Y. et al. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles. Mbio 3, e00270-11 (2012).","journal-title":"Mbio"},{"key":"9807_CR53","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/nm.4224","volume":"22","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat. Med. 22, 1456\u20131464 (2016).","journal-title":"Nat. Med."},{"key":"9807_CR54","doi-asserted-by":"publisher","first-page":"6952","DOI":"10.1021\/ja900186n","volume":"131","author":"C Paes","year":"2009","unstructured":"Paes, C. et al. Atomic-level mapping of antibody epitopes on a GPCR. J. Am. Chem. Soc. 131, 6952\u20136954 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"9807_CR55","doi-asserted-by":"publisher","first-page":"e01456","DOI":"10.7554\/eLife.01456","volume":"2","author":"A Morin","year":"2013","unstructured":"Morin, A. et al. Collaboration gets the most out of software. Elife 2, e01456 (2013).","journal-title":"Elife"},{"key":"9807_CR56","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","volume":"50","author":"Collaborative Computational Project, N.","year":"1994","unstructured":"Collaborative Computational Project, N. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760\u2013763 (1994).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9807_CR57","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1107\/S0907444903008126","volume":"59","author":"E Potterton","year":"2003","unstructured":"Potterton, E., Briggs, P., Turkenburg, M. & Dodson, E. A graphical user interface to the CCP4 program suite. Acta Crystallogr. D Biol. Crystallogr. 59, 1131\u20131137 (2003).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9807_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1107\/S0907444910048675","volume":"67","author":"TG Battye","year":"2011","unstructured":"Battye, T. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D Biol. Crystallogr. 67, 271\u2013281 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9807_CR59","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1107\/S0907444913000061","volume":"69","author":"PR Evans","year":"2013","unstructured":"Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? Acta Crystallogr. D Biol. Crystallogr. 69, 1204\u20131214 (2013).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9807_CR60","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1107\/S0021889807021206","volume":"40","author":"AJ McCoy","year":"2007","unstructured":"McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658\u2013674 (2007).","journal-title":"J. Appl. Crystallogr."},{"key":"9807_CR61","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1107\/S0907444902016657","volume":"58","author":"PD Adams","year":"2002","unstructured":"Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948\u20131954 (2002).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9807_CR62","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"9807_CR63","doi-asserted-by":"publisher","first-page":"eLife.35383","DOI":"10.7554\/eLife.35383","volume":"7","author":"T Grant","year":"2018","unstructured":"Grant, T., Rohou, A. & Grigorieff, N. cisTEM, user-friendly software for single-particle image processing. Elife 7, eLife.35383 (2018).","journal-title":"Elife"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09807-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09807-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T23:30:27Z","timestamp":1671233427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09807-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9807"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09807-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"assertion":[{"value":"10 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.S.M. is a named inventor on patents for vaccines and monoclonal antibodies for RSV, has received research funding from MedImmune and Janssen, has been a paid consultant for MedImmune, and is on the scientific advisory board for Calder Biosciences. M.S.A.G. is a named inventor on a patent application for RSV F-directed single-domain antibodies. P.F.-H., G.P., A.vW., and J.P.M.L. are employees of Janssen, pharmaceutical companies of Johnson & Johnson.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2105"}}